The clinical trial seem to be going as expected, the CR and SD mentioned in yesterday's announcement are still CR and SD as previously reported and LC and other presenters seem to be indicating the clinical trial are progressing as expected for the latest cohort 5 dosage, LC even mention they are already seeing signal from this cohort using the highest dosage to date 3 months ago in her latest Proactive interview (she also mentioned this for months before the CF33 clinical update on low dosage).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)